John Johnson

Affiliations

  • Director at Axogen Inc. (AXGN), 2025-06-20
  • Director at Xeris Biopharma Holdings Inc. (XERS), 2025-06-04
  • Director at Verastem Inc. (VSTM), 2025-05-27
  • Executive Chairman at Applied Therapeutics Inc. (APLT), 2024-12-21
  • Chief Executive Officer at Strongbridge Biopharma Plc (SBBP), 2021-10-06
  • Director at Portola Pharmaceuticals Inc (PTLA), 2020-07-02
  • Chief Executive Officer at Melinta Therapeutics Inc. W (MLNT), 2019-07-03
  • Director at Histogenics Corp (HSGX), 2018-06-19
  • Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
  • Director at Aveo Pharmaceuticals Inc (AVEO), 2018-02-05
  • Pres & Chief Executive Officer at Dendreon Corp (DNDN), 2014-07-08
  • Director at Tranzyme Inc (TZYM), 2012-08-09
  • Chief Executive Officer at Savient Pharmaceuticals Inc (SVNT), 2012-01-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
CEMP $9.10 10,000 $90,980.00 10,000 2014-05-23 Filing
SVNT $2.30 5,000 $11,500.00 270,000 2011-11-21 Filing
SVNT $2.28 10,000 $22,800.00 265,000 2011-11-18 Filing
SVNT $2.36 1,000 $2,359.80 4,000 2011-11-18 Filing
DNDN $6.68 2,500 $16,689.00 12,943 2011-11-04 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AXGN $10.61 4,073 $43,214.53 24,943 2025-06-09 Filing
MLNT $5.57 13,000 $72,441.20 37,400 2019-06-27 Filing
SVNT $2.30 17,650 $40,595.00 252,350 2012-01-03 Filing